시장보고서
상품코드
1873421

세계의 다층 공압출 필름 주입백 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

Multilayer Co-extruded Film Infusion Bags - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 다층 공압출 필름 주입백 시장 규모는 2024년에 17억 9,100만 달러로 추정되며, 2025년부터 2031년까지 예측 기간 동안 CAGR 3.8%로 성장하여 2031년까지 23억 2,600만 달러로 확대될 것으로 예측됩니다.

본 보고서는 다층 공압출 필름 주입백에 대한 최근 관세 조정 및 국제 전략적 대응 조치에 대해 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구축을 종합적으로 평가합니다.

다층 공압출 필름으로 만든 주입백은 수액용 포장용기입니다. 보통 3층 또는 5층 구조로, 서로 다른 고성능 폴리머 소재를 공압출 가공하여 제조됩니다. 내층은 약액과 접촉하는 부분으로 의료용 폴리올레핀 소재로 구성되어 있습니다. 장벽층은 산소와 수증기의 침입을 방지합니다. 보강층은 기계적 강도를 향상시키고, 외층은 우수한 내마모성과 인쇄성을 가지고 있습니다. 이 백은 우수한 차단 성능, 높은 화학적 안정성, 우수한 기계적 특성 등 우수한 특성을 가지고 있어 약액의 안전성과 안정성을 보장합니다. 본 보고서에서는 약액이 들어있지 않은 빈 주입백만을 대상으로 합니다.

다층 공압출 필름 주입백 세계 시장은 기존 PVC 기반 수액 시스템을 대체할 수 있는 비PVC, 생체적합성 및 환경 안전성이 우수한 대체품에 대한 수요 증가가 주요 촉진요인으로 작용하고 있습니다. 폴리올레핀(PP/PE), EVOH 및 기타 열가소성 수지로 구성된 이 첨단 필름 소재는 우수한 내화학성, 열 안정성 및 투명성을 갖추고 있어 다양한 정맥 내(IV) 요법에 이상적입니다. DEHP 가소제 PVC 백의 잠재적 건강 위험, 특히 프탈레이트의 용출에 대한 인식이 높아짐에 따라 EU, 중국, 미국 등 지역에서는 엄격한 규제 조치가 취해지고 있습니다. 또한, 전 세계적으로 고령화와 만성질환 발생률이 증가함에 따라 병원 및 의료기관의 수액 요법 사용이 증가함에 따라 신뢰할 수 있고 가볍고 내구성이 뛰어난 수액 포장재에 대한 수요가 확대되고 있습니다. 제약회사도 다층 공압출 필름이 제공하는 장기 보존성과 오염 위험 감소, 특히 민감한 의약품 및 비경구 영양제에서 이점을 누릴 수 있습니다.

이러한 명백한 장점에도 불구하고, 다층 공압출 필름 주입백 시장은 성장을 저해할 수 있는 몇 가지 과제에 직면해 있습니다. 주요 장벽 중 하나는 고급 다층 필름과 관련된 상대적으로 높은 제조 비용입니다. 이는 공압출 공정의 복잡성과 EVOH 및 고리형 올레핀 폴리머(COP)와 같은 특수한 원료의 필요성에 기인합니다. 이로 인해 비PVC 주입백은 기존 제품보다 가격이 비싸고, 비용 중심의 시장과 예산이 부족한 공공 의료 시스템에서 채택을 제한하고 있습니다. 또 다른 과제는 적합성 및 규제 장벽에 있습니다. 약물의 구성에 따라 다층 필름과의 상호작용이 다르기 때문에 철저한 안정성 테스트와 규제 당국의 승인이 필요하며, 제약사의 시장 출시 시간이 길어집니다. 또한, 이러한 가방의 제조 및 충전에 필요한 제조 인프라와 장비는 전 세계적으로 표준화되어 있지 않아 신규 진입자에게 잠재적인 병목현상이 발생할 수 있습니다. 이러한 요인 외에도 기존 PVC 기반 가방 제조업체와의 치열한 경쟁은 시장 침투 가속화를 제한하고 있습니다.

이 보고서는 다층 공압출 필름 주입 백 세계 시장에 대해 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역 및 국가, 생산능력, 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.

이 보고서는 다층 공압출 필름 주입 백의 시장 규모, 추정 및 예측을 판매량(백만 단위) 및 매출액(백만 달러)으로 제시하고, 2024년을 기준 연도로, 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함합니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 다층 공압출 필름 주입백에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 돕습니다.

시장 세분화

기업별

  • Baxter
  • SSY Group
  • B.Braun
  • Fresenius Kabi
  • ICU Medical
  • Otsuka
  • Technoflex
  • Spirit Medical
  • Valmed
  • Sippex
  • CR Double-Crane
  • Huaren Pharmaceutical
  • Cisen Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Chimin Health
  • Shandong Hualu Pharmaceutical

용량별 부문

  • 250ml
  • 100ml
  • 50ml
  • 500ml
  • 기타

용도별 부문

  • 병원
  • 진료소
  • 기타

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트
    • 기타 중동 및 아프리카
KSM 25.12.09

자주 묻는 질문

  • 다층 공압출 필름 주입백 시장 규모는 어떻게 예측되나요?
  • 다층 공압출 필름 주입백의 주요 특성은 무엇인가요?
  • 다층 공압출 필름 주입백 시장의 주요 촉진 요인은 무엇인가요?
  • 다층 공압출 필름 주입백 시장의 주요 기업은 어디인가요?
  • 다층 공압출 필름 주입백 시장의 주요 과제는 무엇인가요?

The global market for Multilayer Co-extruded Film Infusion Bags was estimated to be worth US$ 1791 million in 2024 and is forecast to a readjusted size of US$ 2326 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Multilayer Co-extruded Film Infusion Bags cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Multilayer co-extruded film infusion bags are packaging containers for infusions. They are made by co-extruding different high-performance polymer materials into a structure usually consisting of 3 or 5 layers. The inner layer is in contact with the medicinal liquid and is made of medical-grade polyolefin materials. The barrier layer can prevent the entry of oxygen and water vapor. The reinforcing layer improves mechanical strength, and the outer layer has good wear - resistance and printability. These bags have excellent properties such as good barrier performance, high chemical stability, and excellent mechanical properties, ensuring the safety and stability of the medicinal liquid. This report only counts empty infusion bags that do not contain pharmaceutical liquids.

The global market for multilayer co-extruded film infusion bags is being driven primarily by the rising demand for non-PVC, biocompatible, and environmentally safer alternatives to traditional PVC-based infusion systems. These advanced film materials, often composed of polyolefin (PP/PE), EVOH, or other thermoplastics, offer excellent chemical resistance, thermal stability, and transparency, which make them ideal for a variety of intravenous (IV) therapies. Growing awareness of the potential health risks associated with DEHP-plasticized PVC bags-especially their leaching of phthalates-has prompted stringent regulatory action in regions like the EU, China, and the United States. Additionally, as the global population ages and chronic disease incidence rises, hospitals and healthcare providers are increasing their usage of infusion therapies, thus expanding the demand for reliable, lightweight, and durable infusion packaging. Pharmaceutical companies are also benefiting from the longer shelf life and reduced contamination risks that multilayer co-extruded films provide, especially for sensitive drug formulations and parenteral nutrition.

Despite the clear advantages, the multilayer co-extruded film infusion bag market faces several challenges that could hamper its growth. One major barrier is the relatively high production cost associated with advanced multilayer films, due to the complexity of co-extrusion processes and the need for specialized raw materials like EVOH and cyclic olefin polymers (COP). This makes non-PVC infusion bags more expensive than their traditional counterparts, limiting adoption in cost-sensitive markets or public healthcare systems with tight budgets. Another challenge lies in compatibility and regulatory hurdles-different drug formulations may interact differently with multilayer films, requiring exhaustive stability testing and regulatory approvals, which increase time-to-market for drug manufacturers. Furthermore, the manufacturing infrastructure and equipment needed for producing and filling these bags are not universally standardized, leading to potential bottlenecks for new entrants. These factors, combined with strong competition from established PVC-based bag manufacturers, pose a constraint on faster market penetration.

This report aims to provide a comprehensive presentation of the global market for Multilayer Co-extruded Film Infusion Bags, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Multilayer Co-extruded Film Infusion Bags by region & country, by Capacity, and by Application.

The Multilayer Co-extruded Film Infusion Bags market size, estimations, and forecasts are provided in terms of sales volume (Million Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multilayer Co-extruded Film Infusion Bags.

Market Segmentation

By Company

  • Baxter
  • SSY Group
  • B.Braun
  • Fresenius Kabi
  • ICU Medical
  • Otsuka
  • Technoflex
  • Spirit Medical
  • Valmed
  • Sippex
  • CR Double-Crane
  • Huaren Pharmaceutical
  • Cisen Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Chimin Health
  • Shandong Hualu Pharmaceutical

Segment by Capacity

  • 250ml
  • 100ml
  • 50ml
  • 500ml
  • Other

Segment by Application

  • Hospital
  • Clinic
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Multilayer Co-extruded Film Infusion Bags manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Capacity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Multilayer Co-extruded Film Infusion Bags in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Multilayer Co-extruded Film Infusion Bags in country level. It provides sigmate data by Capacity, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Multilayer Co-extruded Film Infusion Bags Product Introduction
  • 1.2 Global Multilayer Co-extruded Film Infusion Bags Market Size Forecast
    • 1.2.1 Global Multilayer Co-extruded Film Infusion Bags Sales Value (2020-2031)
    • 1.2.2 Global Multilayer Co-extruded Film Infusion Bags Sales Volume (2020-2031)
    • 1.2.3 Global Multilayer Co-extruded Film Infusion Bags Sales Price (2020-2031)
  • 1.3 Multilayer Co-extruded Film Infusion Bags Market Trends & Drivers
    • 1.3.1 Multilayer Co-extruded Film Infusion Bags Industry Trends
    • 1.3.2 Multilayer Co-extruded Film Infusion Bags Market Drivers & Opportunity
    • 1.3.3 Multilayer Co-extruded Film Infusion Bags Market Challenges
    • 1.3.4 Multilayer Co-extruded Film Infusion Bags Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Multilayer Co-extruded Film Infusion Bags Players Revenue Ranking (2024)
  • 2.2 Global Multilayer Co-extruded Film Infusion Bags Revenue by Company (2020-2025)
  • 2.3 Global Multilayer Co-extruded Film Infusion Bags Players Sales Volume Ranking (2024)
  • 2.4 Global Multilayer Co-extruded Film Infusion Bags Sales Volume by Company Players (2020-2025)
  • 2.5 Global Multilayer Co-extruded Film Infusion Bags Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Multilayer Co-extruded Film Infusion Bags Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Multilayer Co-extruded Film Infusion Bags Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Multilayer Co-extruded Film Infusion Bags
  • 2.9 Multilayer Co-extruded Film Infusion Bags Market Competitive Analysis
    • 2.9.1 Multilayer Co-extruded Film Infusion Bags Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Multilayer Co-extruded Film Infusion Bags Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multilayer Co-extruded Film Infusion Bags as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Capacity

  • 3.1 Introduction by Capacity
    • 3.1.1 250ml
    • 3.1.2 100ml
    • 3.1.3 50ml
    • 3.1.4 500ml
    • 3.1.5 Other
  • 3.2 Global Multilayer Co-extruded Film Infusion Bags Sales Value by Capacity
    • 3.2.1 Global Multilayer Co-extruded Film Infusion Bags Sales Value by Capacity (2020 VS 2024 VS 2031)
    • 3.2.2 Global Multilayer Co-extruded Film Infusion Bags Sales Value, by Capacity (2020-2031)
    • 3.2.3 Global Multilayer Co-extruded Film Infusion Bags Sales Value, by Capacity (%) (2020-2031)
  • 3.3 Global Multilayer Co-extruded Film Infusion Bags Sales Volume by Capacity
    • 3.3.1 Global Multilayer Co-extruded Film Infusion Bags Sales Volume by Capacity (2020 VS 2024 VS 2031)
    • 3.3.2 Global Multilayer Co-extruded Film Infusion Bags Sales Volume, by Capacity (2020-2031)
    • 3.3.3 Global Multilayer Co-extruded Film Infusion Bags Sales Volume, by Capacity (%) (2020-2031)
  • 3.4 Global Multilayer Co-extruded Film Infusion Bags Average Price by Capacity (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Clinic
    • 4.1.3 Other
  • 4.2 Global Multilayer Co-extruded Film Infusion Bags Sales Value by Application
    • 4.2.1 Global Multilayer Co-extruded Film Infusion Bags Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Multilayer Co-extruded Film Infusion Bags Sales Value, by Application (2020-2031)
    • 4.2.3 Global Multilayer Co-extruded Film Infusion Bags Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Multilayer Co-extruded Film Infusion Bags Sales Volume by Application
    • 4.3.1 Global Multilayer Co-extruded Film Infusion Bags Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Multilayer Co-extruded Film Infusion Bags Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Multilayer Co-extruded Film Infusion Bags Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Multilayer Co-extruded Film Infusion Bags Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Multilayer Co-extruded Film Infusion Bags Sales Value by Region
    • 5.1.1 Global Multilayer Co-extruded Film Infusion Bags Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Multilayer Co-extruded Film Infusion Bags Sales Value by Region (2020-2025)
    • 5.1.3 Global Multilayer Co-extruded Film Infusion Bags Sales Value by Region (2026-2031)
    • 5.1.4 Global Multilayer Co-extruded Film Infusion Bags Sales Value by Region (%), (2020-2031)
  • 5.2 Global Multilayer Co-extruded Film Infusion Bags Sales Volume by Region
    • 5.2.1 Global Multilayer Co-extruded Film Infusion Bags Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Multilayer Co-extruded Film Infusion Bags Sales Volume by Region (2020-2025)
    • 5.2.3 Global Multilayer Co-extruded Film Infusion Bags Sales Volume by Region (2026-2031)
    • 5.2.4 Global Multilayer Co-extruded Film Infusion Bags Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Multilayer Co-extruded Film Infusion Bags Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 5.4.2 North America Multilayer Co-extruded Film Infusion Bags Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 5.5.2 Europe Multilayer Co-extruded Film Infusion Bags Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Multilayer Co-extruded Film Infusion Bags Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 5.7.2 South America Multilayer Co-extruded Film Infusion Bags Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Multilayer Co-extruded Film Infusion Bags Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Multilayer Co-extruded Film Infusion Bags Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Multilayer Co-extruded Film Infusion Bags Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Multilayer Co-extruded Film Infusion Bags Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 6.3.2 United States Multilayer Co-extruded Film Infusion Bags Sales Value by Capacity (%), 2024 VS 2031
    • 6.3.3 United States Multilayer Co-extruded Film Infusion Bags Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 6.4.2 Europe Multilayer Co-extruded Film Infusion Bags Sales Value by Capacity (%), 2024 VS 2031
    • 6.4.3 Europe Multilayer Co-extruded Film Infusion Bags Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 6.5.2 China Multilayer Co-extruded Film Infusion Bags Sales Value by Capacity (%), 2024 VS 2031
    • 6.5.3 China Multilayer Co-extruded Film Infusion Bags Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 6.6.2 Japan Multilayer Co-extruded Film Infusion Bags Sales Value by Capacity (%), 2024 VS 2031
    • 6.6.3 Japan Multilayer Co-extruded Film Infusion Bags Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 6.7.2 South Korea Multilayer Co-extruded Film Infusion Bags Sales Value by Capacity (%), 2024 VS 2031
    • 6.7.3 South Korea Multilayer Co-extruded Film Infusion Bags Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Multilayer Co-extruded Film Infusion Bags Sales Value by Capacity (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Multilayer Co-extruded Film Infusion Bags Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Multilayer Co-extruded Film Infusion Bags Sales Value, 2020-2031
    • 6.9.2 India Multilayer Co-extruded Film Infusion Bags Sales Value by Capacity (%), 2024 VS 2031
    • 6.9.3 India Multilayer Co-extruded Film Infusion Bags Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Baxter
    • 7.1.1 Baxter Company Information
    • 7.1.2 Baxter Introduction and Business Overview
    • 7.1.3 Baxter Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Baxter Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.1.5 Baxter Recent Development
  • 7.2 SSY Group
    • 7.2.1 SSY Group Company Information
    • 7.2.2 SSY Group Introduction and Business Overview
    • 7.2.3 SSY Group Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 SSY Group Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.2.5 SSY Group Recent Development
  • 7.3 B.Braun
    • 7.3.1 B.Braun Company Information
    • 7.3.2 B.Braun Introduction and Business Overview
    • 7.3.3 B.Braun Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 B.Braun Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.3.5 B.Braun Recent Development
  • 7.4 Fresenius Kabi
    • 7.4.1 Fresenius Kabi Company Information
    • 7.4.2 Fresenius Kabi Introduction and Business Overview
    • 7.4.3 Fresenius Kabi Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Fresenius Kabi Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.4.5 Fresenius Kabi Recent Development
  • 7.5 ICU Medical
    • 7.5.1 ICU Medical Company Information
    • 7.5.2 ICU Medical Introduction and Business Overview
    • 7.5.3 ICU Medical Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 ICU Medical Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.5.5 ICU Medical Recent Development
  • 7.6 Otsuka
    • 7.6.1 Otsuka Company Information
    • 7.6.2 Otsuka Introduction and Business Overview
    • 7.6.3 Otsuka Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Otsuka Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.6.5 Otsuka Recent Development
  • 7.7 Technoflex
    • 7.7.1 Technoflex Company Information
    • 7.7.2 Technoflex Introduction and Business Overview
    • 7.7.3 Technoflex Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Technoflex Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.7.5 Technoflex Recent Development
  • 7.8 Spirit Medical
    • 7.8.1 Spirit Medical Company Information
    • 7.8.2 Spirit Medical Introduction and Business Overview
    • 7.8.3 Spirit Medical Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Spirit Medical Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.8.5 Spirit Medical Recent Development
  • 7.9 Valmed
    • 7.9.1 Valmed Company Information
    • 7.9.2 Valmed Introduction and Business Overview
    • 7.9.3 Valmed Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Valmed Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.9.5 Valmed Recent Development
  • 7.10 Sippex
    • 7.10.1 Sippex Company Information
    • 7.10.2 Sippex Introduction and Business Overview
    • 7.10.3 Sippex Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Sippex Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.10.5 Sippex Recent Development
  • 7.11 CR Double-Crane
    • 7.11.1 CR Double-Crane Company Information
    • 7.11.2 CR Double-Crane Introduction and Business Overview
    • 7.11.3 CR Double-Crane Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 CR Double-Crane Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.11.5 CR Double-Crane Recent Development
  • 7.12 Huaren Pharmaceutical
    • 7.12.1 Huaren Pharmaceutical Company Information
    • 7.12.2 Huaren Pharmaceutical Introduction and Business Overview
    • 7.12.3 Huaren Pharmaceutical Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Huaren Pharmaceutical Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.12.5 Huaren Pharmaceutical Recent Development
  • 7.13 Cisen Pharmaceutical
    • 7.13.1 Cisen Pharmaceutical Company Information
    • 7.13.2 Cisen Pharmaceutical Introduction and Business Overview
    • 7.13.3 Cisen Pharmaceutical Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Cisen Pharmaceutical Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.13.5 Cisen Pharmaceutical Recent Development
  • 7.14 Sichuan Kelun Pharmaceutical
    • 7.14.1 Sichuan Kelun Pharmaceutical Company Information
    • 7.14.2 Sichuan Kelun Pharmaceutical Introduction and Business Overview
    • 7.14.3 Sichuan Kelun Pharmaceutical Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Sichuan Kelun Pharmaceutical Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.14.5 Sichuan Kelun Pharmaceutical Recent Development
  • 7.15 Chimin Health
    • 7.15.1 Chimin Health Company Information
    • 7.15.2 Chimin Health Introduction and Business Overview
    • 7.15.3 Chimin Health Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Chimin Health Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.15.5 Chimin Health Recent Development
  • 7.16 Shandong Hualu Pharmaceutical
    • 7.16.1 Shandong Hualu Pharmaceutical Company Information
    • 7.16.2 Shandong Hualu Pharmaceutical Introduction and Business Overview
    • 7.16.3 Shandong Hualu Pharmaceutical Multilayer Co-extruded Film Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Shandong Hualu Pharmaceutical Multilayer Co-extruded Film Infusion Bags Product Offerings
    • 7.16.5 Shandong Hualu Pharmaceutical Recent Development

8 Industry Chain Analysis

  • 8.1 Multilayer Co-extruded Film Infusion Bags Industrial Chain
  • 8.2 Multilayer Co-extruded Film Infusion Bags Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Multilayer Co-extruded Film Infusion Bags Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Multilayer Co-extruded Film Infusion Bags Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제